These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30635341)

  • 1. PRMT5-mediated H4R3sme2 Confers Cell Differentiation in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia.
    Mei M; Zhang R; Zhou ZW; Ying Z; Wang J; Zhang H; Zheng H; Bao S
    Clin Cancer Res; 2019 Apr; 25(8):2633-2643. PubMed ID: 30635341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells.
    Wang L; Pal S; Sif S
    Mol Cell Biol; 2008 Oct; 28(20):6262-77. PubMed ID: 18694959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prmt5 promotes ciliated cell specification of airway epithelial progenitors via transcriptional inhibition of Tp63.
    Li Q; Jiao J; Heng Y; Lu Q; Zheng Y; Li H; Cai J; Mei M; Bao S
    J Biol Chem; 2023 Aug; 299(8):104964. PubMed ID: 37364687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin.
    Cai S; Wang P; Xie T; Li Z; Li J; Lan R; Ding Y; Lu J; Ye J; Wang J; Li Z; Liu P
    Pharmacol Res; 2020 Nov; 161():105104. PubMed ID: 32739429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.
    Tarighat SS; Santhanam R; Frankhouser D; Radomska HS; Lai H; Anghelina M; Wang H; Huang X; Alinari L; Walker A; Caligiuri MA; Croce CM; Li L; Garzon R; Li C; Baiocchi RA; Marcucci G
    Leukemia; 2016 Apr; 30(4):789-99. PubMed ID: 26536822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
    Shailesh H; Siveen KS; Sif S
    J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone arginine methylation by Prmt5 is required for lung branching morphogenesis through repression of BMP signaling.
    Li Q; Jiao J; Li H; Wan H; Zheng C; Cai J; Bao S
    J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29950483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.
    Saha K; Adhikary G; Eckert RL
    J Invest Dermatol; 2016 Jan; 136(1):214-224. PubMed ID: 26763441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
    Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
    J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression.
    Liu M; Yao B; Gui T; Guo C; Wu X; Li J; Ma L; Deng Y; Xu P; Wang Y; Yang D; Li Q; Zeng X; Li X; Hu R; Ge J; Yu Z; Chen Y; Chen B; Ju J; Zhao Q
    Theranostics; 2020; 10(10):4437-4452. PubMed ID: 32292506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
    Fulton MD; Dang T; Brown T; Zheng YG
    Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
    Chen H; Lorton B; Gupta V; Shechter D
    Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.
    Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma.
    Xia T; Liu M; Zhao Q; Ouyang J; Xu P; Chen B
    Cell Death Dis; 2021 Sep; 12(10):851. PubMed ID: 34531375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRMT5 inhibition promotes osteogenic differentiation of mesenchymal stromal cells and represses basal interferon stimulated gene expression.
    Kota SK; Roening C; Patel N; Kota SB; Baron R
    Bone; 2018 Dec; 117():37-46. PubMed ID: 30189247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
    Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
    Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.
    Serio J; Ropa J; Chen W; Mysliwski M; Saha N; Chen L; Wang J; Miao H; Cierpicki T; Grembecka J; Muntean AG
    Oncogene; 2018 Jan; 37(4):450-460. PubMed ID: 28945229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2.
    Liu F; Xu Y; Lu X; Hamard PJ; Karl DL; Man N; Mookhtiar AK; Martinez C; Lossos IS; Sun J; Nimer SD
    Nucleic Acids Res; 2020 Apr; 48(6):2956-2968. PubMed ID: 32025719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of human B cell precursor-leukemia cell lines.
    Matsuo Y; Drexler HG
    Leuk Res; 1998 Jul; 22(7):567-79. PubMed ID: 9680106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.